Open AccessAdjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
Author(s) -
Sara M. Tolaney,
William T. Barry,
Chau T. Dang,
Denise A. Yardley,
Beverly Moy,
P. Kelly Marcom,
Kathy S. Albain,
Hope S. Rugo,
Matthew J. Ellis,
Iuliana Shapira,
Antonio C. Wolff,
Lisa A. Carey,
Beth Overmoyer,
Ann H. Partridge,
Hao Guo,
Clifford A. Hudis,
Ian E. Krop,
Harold J. Burstein,
Eric P. Winer
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/5g5m-fr14
Subject(s) - trastuzumab , paclitaxel , oncology , breast cancer , adjuvant , medicine , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom